Kangmei Pharma | 600518 - Ebit


Kangmei Pharma reported CNY-35.26M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -952K 60K Jun/2026
Avita Medical AUD -6.17M 4.22M Jun/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Genomma Lab Internacional MXN 829.49M 47.71M Sep/2026
Hypermarcas BRL 711.46M 9.6M Sep/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Jiangsu Hengrui CNY 2.85B 1.17B Sep/2026
Kangmei Pharma CNY -35.26M 22.54M Jun/2026
Moderna USD 130M 945M Sep/2026
Organon & Co USD 377M 86M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Sh Fosun Pharma CNY 863.03M 301.08M Sep/2026
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Viatris USD 255.5M 181.8M Sep/2026
Wuxi Apptec CNY 7.44B 390.43M Sep/2026
Xeris Pharmaceuticals USD -24.15M 33.27M Jun/2026
Zz Pientze Pharmaceu CNY 222.81M 140.02M Sep/2026